HPLC Columns
Sepax Technologies Inc Sepax HPLC Column GP-C4, 1.8 µm, 120 Å, 2.1 x 150 mm
Monomeric and fully endcapped GP-C4 packing is bonded with butyl groups that lead to moderate hydrophobicity. GP-C4 columns have unique selectivity and peak symmetry with moderate retention for separations of acidic, neutral and basic organic compounds, such as pharmaceuticals, peptides, and organic acids.
Sepax Technologies Inc Sepax HPLC Column HP-Cyano, 1.8 µm, 120 Å, 2.1 x 50 mm
Synthesized with monomeric and fully endcapped chemistry, HP-Cyano phase is bonded with propylcyano functional group that allows special interaction with polar compounds. The monomeric bonding chemistry enables high efficiency and high resolution separation of peptide, proteins, acidic, neutral and basic organic compound, and pharmaceuticals.
Sepax Technologies Inc Sepax HPLC Column Bio-C4, 10 µm, 300 Å, 10 x 250 mm
Monomeric and fully endcapped Bio-C4 packing is bonded with butyl groups that lead to moderate hydrophobicity. Bio-C4 packings of 300 Å pore size selection are ideal for high resolution mapping of peptides and separation of intact proteins, and natural and synthetic peptides.
Sepax Technologies Inc Sepax HPLC Column PolyRP-500, 10 µm, 2.1 x 30 mm
GP-C8 phase is synthesized with monomeric and fully endcapped chemistry. The uniform octyl stationary phase allows high efficiency with lower hydrophobicity compared to ODS phase. GP-C8 phase is suitable for separating compounds with a wide range of hydrophobicity. It is highly recommended for separating the compounds which are too strongly retained on C18 phases.
Sepax Technologies Inc Sepax HPLC Column HP-C18, 10 µm, 120 Å, 21.2 x 50 mm
HP-C18 uses full coverage bonded silica packing, which provides high stability. Compatible with 100% aqueous mobile phase and suitable for separations of acidic, neutral and basic organic compounds, as well as pharmaceuticals and peptides. ODS monolayer formed by special bonding chemistry does not collapse in pure aqueous solution.
Sepax Technologies Inc Sepax HPLC Column HP-Cyano, 10 µm, 120 Å, 7.8 x 250 mm
Synthesized with monomeric and fully endcapped chemistry, HP-Cyano phase is bonded with propylcyano functional group that allows special interaction with polar compounds. The monomeric bonding chemistry enables high efficiency and high resolution separation of peptide, proteins, acidic, neutral and basic organic compound, and pharmaceuticals.
Sepax Technologies Inc Sepax HPLC Column GP-C4, 3 µm, 120 Å, 4.6 x 50 mm
Monomeric and fully endcapped GP-C4 packing is bonded with butyl groups that lead to moderate hydrophobicity. GP-C4 columns have unique selectivity and peak symmetry with moderate retention for separations of acidic, neutral and basic organic compounds, such as pharmaceuticals, peptides, and organic acids.
Sepax Technologies Inc Sepax HPLC Column BR-C18, 10 µm, 120 Å, 7.8 x 150 mm
Utilizing highest purity and enhanced mechanical stability silica and pure bonding reagents, BR-C18 bonded phases have been innovatively and specially designed to ensure maximum surface coverage and full end-capping, which leads to carbon content as high as 19.0%. The bonding chemistry is completely controlled that results in very reliable column-to-column reproducibility. The maximum surface coverage allows BR-C18 to have exceptional stability, resulting in high pH stability in the range of 1.5 to 10.5.
Sepax Technologies Inc Sepax HPLC Column SRT-C SEC-2000, 5 µm, 7.8 x 50 mm
SRT-C SEC phase, developed based on innovative surface coating technology, comprises of uniform, hydrophilic, and neutral nanometer thick film chemically bonded to high purity and mechanically stabilized silica. SRT-C, uses lay-down monolayer on porous silica as oppose to SRT of stand-up monolayer, offers ideal phase chemistry for hydrophobic samples like insulin, membrane protein monoclonal antibodies derivatized with polymer branches (polypeptide or PEG) separation.
Sepax Technologies Inc Sepax HPLC Column Zenix-C SEC-300, 3 µm, 7.8 x 200 mm
Zenix™-C SEC phase, developed based on innovative surface coating technology, comprises of uniform, hydrophilic, and neutral nanometer thick film chemically bonded to high purity and mechanically stabilized silica. Zenix™-C, uses lay-down monolayer on porous silica as oppose to Zenix of stand-up monolayer, offers ideal phase chemistry for hydrophobic samples like insulin, membrane protein monoclonal antibodies derivatized with polymer branches (polypeptide or PEG) separation. The 3µm based packing material allows for high resolution and performance separation.
Sepax Technologies Inc Sepax HPLC Column GP-C4, 3 µm, 120 Å, 2.1 x 150 mm
Monomeric and fully endcapped GP-C4 packing is bonded with butyl groups that lead to moderate hydrophobicity. GP-C4 columns have unique selectivity and peak symmetry with moderate retention for separations of acidic, neutral and basic organic compounds, such as pharmaceuticals, peptides, and organic acids.
Sepax Technologies Inc Sepax HPLC Column PolyRP-100, 5 µm, 10 x 100 mm
GP-C8 phase is synthesized with monomeric and fully endcapped chemistry. The uniform octyl stationary phase allows high efficiency with lower hydrophobicity compared to ODS phase. GP-C8 phase is suitable for separating compounds with a wide range of hydrophobicity. It is highly recommended for separating the compounds which are too strongly retained on C18 phases.
Sepax Technologies Inc Sepax HPLC Column PolyRP-1000, 5 µm, 2.1 x 250 mm
GP-C8 phase is synthesized with monomeric and fully endcapped chemistry. The uniform octyl stationary phase allows high efficiency with lower hydrophobicity compared to ODS phase. GP-C8 phase is suitable for separating compounds with a wide range of hydrophobicity. It is highly recommended for separating the compounds which are too strongly retained on C18 phases.
Sepax Technologies Inc Sepax HPLC Column HP-Amino, 3 µm, 120 Å, 2.1 x 30 mm
Synthesized with polymeric chemistry, HP-Amino phase is bonded with aminopropyl functional group. HP-Amino phase is compatible with versatile mobile phases from non-aqueous solvents, such as hexane/ethyl acetate and chloroform/methanol, to aqueous solutions. It is recommended for separations of sugars, nucleotides, basic organic compounds, as well as the pharmaceuticals.
Sepax Technologies Inc Sepax HPLC Column Polar-Imidazole, 1.8 µm, 120 Å, 4.6 x 50 mm
Utilizing highest purity and enhanced mechanical stability silica and pure bonding reagents, Polar-Imidazole phase is bonded with imidazole functional groups. With a polar and N-containing ring structure, Polar-Pyridine phase is a weak base and adequate for many applications, such as pharmaceuticals, peptides, sugars, and nucleotides.